Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
09/2010
09/30/2010CA2753388A1 Compounds compositions and methods of treating cancer and fibrotic diseases
09/29/2010EP2233498A1 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same
09/29/2010EP2231659A1 Translocator protein ligands
09/29/2010EP2231201A1 Selective radiolabeling of biomolecules
09/29/2010EP1095274B1 Trifunctional reagent for conjugation to a biomolecule
09/29/2010CN1946432B Particulate materials and compositions for radio therapy
09/28/2010US7803754 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
09/28/2010US7803753 combination of GPR119 agonist with a dipeptidyl peptidase IV (DPP-IV) inhibitor such that combination provides effect in lowering a blood glucose level or in increasing blood GLP-1 level over that provided by GPR119 agonist or DPP-IV inhibitor alone; for treating or preventing diabetes; synergistic
09/28/2010US7803637 Compositions and methods for treatment of neoplastic disease
09/28/2010US7803405 Vesicle encapsulating an aqueous system of a polymer and can exist as more than one phase depending on temperature and composition
09/28/2010US7803399 Delivery system for nucleic acids
09/28/2010US7803372 Mixture of anti-CEA (carcinogenicembryonic antigen) monoclonal antibody (MAb) or fragment and drug
09/28/2010US7803352 Binding a contrasting complex comprising a contrast material and a thrombolytic or clot dissolving agent to the blood clot; exits body without causing either kidney toxicity, allergic reaction, or stimulation of atherogenesis
09/28/2010US7803351 Blood brain barrier permeation peptides
09/28/2010US7803350 Radioactive arsenic-containing compounds and their uses in the treatment of tumors
09/28/2010CA2366789C Fatty acid analogs for diagnosis of coronary artery disease
09/23/2010WO2010107832A1 Lhrh-ii peptide analogs
09/23/2010WO2010107029A1 Molecular probe precursor for pancreatic islet imaging and use of same
09/23/2010US20100240696 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/23/2010US20100239587 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
09/23/2010US20100239497 Oxidized avidin with high residency time in the treated tissues
09/23/2010US20100239496 Imaging agents for detecting neurological disorders
09/23/2010US20100236958 Radiopharmaceutical composition
09/23/2010DE102009013456A1 New nanoparticle, comprising core and immobilized ligand (for G-protein coupled receptor) in its surface, useful e.g. in drug targeting and tumor therapy, where the nanoparticle e.g. binds to cells having appropriate receptor to the ligand
09/22/2010EP2230320A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
09/22/2010EP2230244A1 Phosphorus polymers and their uses
09/22/2010EP2229957A2 Stabilization of aqueous compositions of 18f-isotope labelled 2-fluoro-2-deoxy-d-glucose with ethanol
09/22/2010EP2229411A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
09/22/2010EP1601384B1 Methods of radiofluorination of biologically active vectors
09/22/2010CN1693416B Fluorescent microball and process and application for preparing spray drying thereof
09/22/2010CN101842101A Salicylanilide modified peptides for use as oral therapeutics
09/22/2010CN101838345A Fluorine-18-labelled galactosylated chitosan compound and preparation method thereof
09/22/2010CN101838289A Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
09/21/2010US7799947 radiolabelled amidine derivatives such as N-(3,5-dichlorobenzyl)-4-iodophenyl amidine suitable for imaging with tomography; selective antagonists of N-methylaspartic acid receptors, used for the diagnosis of pain, epilepsy, stroke, ischemia, spasms, neurodegenerative and psychological disorders
09/21/2010US7799576 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
09/21/2010US7799327 Employing nonimmunogenic blood products from patients with autoimmune disease
09/21/2010US7799070 Coated implantable medical device
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2338073C Novel urokinase inhibitors
09/16/2010US20100233082 68GA-Labeled Peptide-Based Radiopharmaceuticals
09/16/2010US20100233081 Methods for administration of radiotherapeutic agents
09/16/2010US20100233080 Antigen Binding Molecules that Bind EGFR, Vectors Encoding Same, and Uses Thereof
09/16/2010US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof
09/16/2010US20100233078 Microorganisms for imaging and/or treatment of tumors
09/15/2010EP2228074A1 A tumor targeting protein conjugate and a method for preparing the same
09/15/2010CN101830937A Visualized double-reaction tube fluorine-18 multifunctional automated synthesis module
09/15/2010CN101829341A Hydroxyapatite nanoparticle radionuclide marked product and preparation method thereof
09/15/2010CN101829340A Medicine composition for treating solid tumors as well preparation method and application thereof
09/15/2010CN101829324A Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-CD20 antibody
09/14/2010US7795378 Erectile dysfunction
09/14/2010US7795215 MNTF peptides and compositions and methods of use
09/14/2010US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
09/14/2010US7794755 Process for preparation of swellable and deformable microspheres
09/14/2010US7794691 treating cancer by alpha-radioimmunotherapy by administering radioconjugate comprising targeting moiety having binding specificity for cancer cells, and radionuclides selected from Th-226 or U-230 wherein targeting moiety binds to cancer cells, thus exposing cells to effective number of alpha particles
09/14/2010CA2376159C Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method
09/14/2010CA2319446C Radiopaque implantable collagenous biomaterial device
09/14/2010CA2146693C Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
09/10/2010WO2010101118A1 Method of synthesizing [18f]sfb using microsynthesis technique
09/10/2010WO2010039609A3 Conjugates of hexose and metal coordinating compounds for imaging purposes
09/10/2010WO2008117097A3 Filling system for potentially hazardous materials
09/09/2010US20100228012 Pendant fatty acid imaging agents
09/09/2010US20100228007 Mhc-peptide complex binding ligands
09/09/2010US20100226974 Antibody recognizing antigen
09/09/2010US20100226854 MHC Peptide Complexes and Uses Thereof in Infectious Diseases
09/09/2010US20100226853 Fluorine-18 derivatives of dasatinib and uses thereof
09/09/2010US20100226852 Clk-peptide and slk-peptide
09/08/2010EP2225271A2 New non-selective somatostatin analogues
09/08/2010EP2224959A1 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis
09/08/2010EP1429797B1 Diagnosis and treatment of malignant neoplasms
09/08/2010CN101827614A Use of lanthanide-based nanoparticles as radiosensitizing agents
09/08/2010CN101824090A Monoclonal antibody hpam4
09/08/2010CN101200448B Beta-elemene derivatives as well as Re complex and 188Re marker thereof
09/07/2010US7790860 Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids
09/07/2010US7790683 Modulation body weights; dietetics; eating disorders; polypeptide having specific amino acid sequence; utilization of D-isoform amino acid substituted leptin-like polypeptides for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass
09/07/2010US7790162 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
09/07/2010US7790144 Receptor-avid exogenous optical contrast and therapeutic agents
09/07/2010US7790142 Using a radiolabeled fatty acid analog such as endo-[18F] fluoro- or [123I]iodo-3,4-cyclopropylheptadecanoic acid localized in tissue of interest, imaging, determining blood flow rate
09/07/2010US7790141 oligomeric, homopolymeric, water soluble, hydrolytically stable and non-ionic compounds and compositions useful in medical diagnostic and pharmaceutical field in drug delivery, imaging
09/07/2010US7790140 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery
09/07/2010CA2368676C Sphingomyelin containing preparation
09/02/2010WO2010099273A1 Methods and compositions for protein labelling
09/02/2010WO2010097367A1 Radiolabelled pde10 ligands
09/02/2010WO2010096930A1 Single chain antibodies for targeting pancreatic alpha and beta cells
09/02/2010US20100221182 Ligands for imaging cardiac innervation
09/02/2010US20100221181 Method of differentially diagnosing different types of dementia
09/02/2010US20100221180 In vivo imaging of myelination
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
09/02/2010US20100221177 RS7 Antibodies
09/02/2010US20100221176 Methods and compositions for protein labelling
09/02/2010US20100221175 Antibody Therapy
09/02/2010CA2752884A1 Methods and compositions for protein labelling
09/01/2010EP2222689A1 Compounds for therapy and diagnosis
09/01/2010EP1814857B1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands
09/01/2010CN101816788A Compositions and methods for the therapy and diagnosis of ovarian cancer
09/01/2010CN101428148B RGD polypeptide radiopharmaceuticals and preparation method thereof
08/2010
08/31/2010US7787937 Methods, systems, and associated implantable devices for detecting radiation in patients undergoing treatment for cancer
08/31/2010US7786119 Drug conjugates of ion channel modulating compounds
08/31/2010US7786102 Steroids as agonists for FXR
08/31/2010US7785817 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics
08/31/2010US7785569 Measuring stomach discharging; analyzing emisison in breath; calibration
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 243